Failed in phase 2
Opicinumab: repair myelin in optic neuritis
optic neuritis · Remyelination / oligodendrocyte repair
Controlled phase 2 trials did not meet their main goal for this group.
- Trials
- 2
- Running now
- 0
- Controlled phase 2/3 trials
- 2
- People in controlled trials
- 134
How the verdict was reached
Negative in phase 2
| Trial | Phase | Participants | Started | Result | Counted |
|---|---|---|---|---|---|
| Opicinumab, phase 2 | Phase 2 | 82 | 2012 | Missed its main goal | Counted |
| RENEWED | Phase 2 | 52 | 2016 | Missed its main goal | Counted |
Counted: 2. Will count later: 0. Not counted: 0.
Lab evidence
Lab studies in animals or cells. Results in animals often do not hold in people, and these studies never change the status of an idea.
Loading lab studies…
Loading reviews and guidelines…
History
- Oct 2026Trials: 3 → 2
- Oct 2026Status changed from Results pending to Failed in phase 2
- Oct 2026First listed as Results pending
Related hypotheses
Assembled by software from public sources.